Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Keytruda
Pharma
Padcev-Keytruda combo wins in MIBC amid evolving landscape
Unlike the combo’s conclusive win in cisplatin-ineligible MIBC, the latest triumph in chemo-eligible patients comes with some questions.
Angus Liu
Feb 27, 2026 10:00am
Merck splits human pharma business, establishing oncology unit
Feb 23, 2026 10:25am
FDA endorses Merck's Keytruda for the 1st time in ovarian cancer
Feb 11, 2026 10:04am
Merck lines up $70B+ in revenue opportunities over next decade
Feb 3, 2026 12:14pm
Keytruda, Padcev keep winning streak in bladder cancer
Dec 17, 2025 9:53am
Merck's Keytruda SC launch in Germany faces legal hurdle
Dec 5, 2025 9:30am
